Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Assessment for Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration

NCT02964637 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02964637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Assessment for Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2015
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis and/or frontotemporal dementia, behavioral variant frontotemporal dementia, corticobasal syndrome, progressive nonfluent aphasia, progressive supranuclear palsy, semantic dementia